resveratrol has been researched along with Diffuse Parenchymal Lung Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, L; Chen, X; Fan, X; Li, W; Liu, N; Shao, Y; Wang, H; Ye, J; Zhao, D | 1 |
| Cheriet, T; Eid, AH; Giordo, R; Pintus, G; Posadino, AM; Ramli, I; Zayed, H | 1 |
| Bao, L; Lin, Z; Lyu, B; Lyu, L; Wang, X; Yang, G | 1 |
1 review(s) available for resveratrol and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Potential Therapeutic Targets of Resveratrol in the Prevention and Treatment of Pulmonary Fibrosis.
Topics: Arthritis, Rheumatoid; Humans; Lung Diseases, Interstitial; Pulmonary Fibrosis; Resveratrol; Scleroderma, Systemic | 2023 |
2 other study(ies) available for resveratrol and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Resveratrol Ameliorates Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease via the Autophagy-Lysosome Pathway.
Topics: Animals; Arthritis, Rheumatoid; Autophagy; Fibrosis; Lung Diseases, Interstitial; Pulmonary Fibrosis; Resveratrol | 2022 |
Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway.
Topics: Animals; Antioxidants; Arthritis, Experimental; Arthritis, Rheumatoid; Cytokines; Janus Kinases; Lung Diseases, Interstitial; Male; RANK Ligand; Rats; Rats, Wistar; Resveratrol; Signal Transduction; STAT Transcription Factors | 2019 |